GST issue haunts chemists across country

Published On 2021-02-27 12:58 GMT   |   Update On 2021-02-27 12:58 GMT

New Delhi: While medicine sale has taken prime most spot with the Covid-19 pandemic, the issue of GST continues to haunt 9.40 lakh chemists of the country. In this regard, the All India Organization of Chemists and Druggists (AIOCD) has sent a memorandum to the Finance Minister asking her to correct GST anomalies with immediate attention.The chemist body drew further attention to...

Login or Register to read the full article

New Delhi: While medicine sale has taken prime most spot with the Covid-19 pandemic, the issue of GST continues to haunt 9.40 lakh chemists of the country. In this regard, the All India Organization of Chemists and Druggists (AIOCD) has sent a memorandum to the Finance Minister asking her to correct GST anomalies with immediate attention.

The chemist body drew further attention to the discrepancies in the memorandum.

Also Read: Indian Pharma Sees Decline In August 2020, Anti-Infectives, Respiratory Segments See Major Slumps: AIOCD-AWACS Report

J.S.Shinde, President, and Rajiv Singhal General Secretary of the Association of said that despite all the amendments, the inconsistencies in the GST law of the country are not being corrected even due to which there is a lot of anger among the traders.

They added that being public health care chemists and want to maintain the availability of medicines during this crucial Corona period, they will not be involved in any BANDH, however, they warned if the above discrepancies are not taken care of then chemists in the country will also be forced to agitate.

AIOCD further added that it anticipates that the Government will find all the suggestions of the Organization practical and will provide relief to the business by making necessary simplification of GST by giving necessary instructions for the implementation of 'Ease of Doing Business' of the respected Prime Minister.

Also Read: Intas Pharma COVID-19 specific Hyperimmune Globulin gets DCGI nod to conduct clinical trial

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News